Literature DB >> 17686854

The imidazopyrrolopyridine analogue AG110 is a novel, highly selective inhibitor of pestiviruses that targets the viral RNA-dependent RNA polymerase at a hot spot for inhibition of viral replication.

Jan Paeshuyse1, Jean-Michel Chezal, Matheus Froeyen, Pieter Leyssen, Hélène Dutartre, Robert Vrancken, Bruno Canard, Carine Letellier, Tong Li, Harald Mittendorfer, Frank Koenen, Pierre Kerkhofs, Erik De Clercq, Piet Herdewijn, Gerhard Puerstinger, Alain Gueiffier, Olivier Chavignon, Jean-Claude Teulade, Johan Neyts.   

Abstract

Ethyl 2-methylimidazo[1,2-a]pyrrolo[2,3-c]pyridin-8-carboxylate (AG110) was identified as a potent inhibitor of pestivirus replication. The 50% effective concentration values for inhibition of bovine viral diarrhea virus (BVDV)-induced cytopathic effect, viral RNA synthesis, and production of infectious virus were 1.2 +/- 0.5 microM, 5 +/- 1 microM, and 2.3 +/- 0.3 microM, respectively. AG110 proved inactive against the hepatitis C virus and a flavivirus. AG110 inhibits BVDV replication at a time point that coincides with the onset of intracellular viral RNA synthesis. Drug-resistant mutants carry the E291G mutation in the viral RNA-dependent RNA polymerase (RdRp). AG110-resistant virus is cross-resistant to the cyclic urea compound 1453 which also selects for the E291G drug resistance mutation. Moreover, BVDV that carries the F224S mutation (because of resistance to the imidazopyridine 5-[(4-bromophenyl)methyl]-2-phenyl-5H-imidazo[4,5-c]pyridine [BPIP]and VP32947) is also resistant to AG110. AG110 did not inhibit the in vitro activity of recombinant BVDV RdRp but inhibited the activity of BVDV replication complexes (RCs). Molecular modeling revealed that E291 is located in a small cavity near the tip of the finger domain of the RdRp about 7 A away from F224. Docking of AG110 in the crystal structure of the BVDV RdRp revealed several potential contacts including with Y257. The E291G mutation might enable the free rotation of Y257, which might in turn destabilize the backbone of the loop formed by residues 223 to 226, rendering more mobility to F224 and, hence, reducing the affinity for BPIP and VP32947. It is concluded that a single drug-binding pocket exists within the finger domain region of the BVDV RdRp that consists of two separate but potentially overlapping binding sites rather than two distinct drug-binding pockets.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17686854      PMCID: PMC2045526          DOI: 10.1128/JVI.00388-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Architecture of the flaviviral replication complex. Protease, nuclease, and detergents reveal encasement within double-layered membrane compartments.

Authors:  Pradeep Devappa Uchil; Vijaya Satchidanandam
Journal:  J Biol Chem       Date:  2003-04-16       Impact factor: 5.157

2.  A novel selective broad-spectrum anti-DNA virus agent.

Authors:  E De Clercq; A Holý; I Rosenberg; T Sakuma; J Balzarini; P C Maudgal
Journal:  Nature       Date:  1986 Oct 2-8       Impact factor: 49.962

3.  Satisfying hydrogen bonding potential in proteins.

Authors:  I K McDonald; J M Thornton
Journal:  J Mol Biol       Date:  1994-05-20       Impact factor: 5.469

Review 4.  The 1997-1998 epidemic of classical swine fever in the Netherlands.

Authors:  A Stegeman; A Elbers; H de Smit; H Moser; J Smak; F Pluimers
Journal:  Vet Microbiol       Date:  2000-04-13       Impact factor: 3.293

Review 5.  Classical swine fever: the global situation.

Authors:  S Edwards; A Fukusho; P C Lefèvre; A Lipowski; Z Pejsak; P Roehe; J Westergaard
Journal:  Vet Microbiol       Date:  2000-04-13       Impact factor: 3.293

6.  Substituted 5-benzyl-2-phenyl-5H-imidazo[4,5-c]pyridines: a new class of pestivirus inhibitors.

Authors:  Gerhard Puerstinger; Jan Paeshuyse; Piet Herdewijn; Jef Rozenski; Erik De Clercq; Johan Neyts
Journal:  Bioorg Med Chem Lett       Date:  2006-08-09       Impact factor: 2.823

7.  Prevention and elimination of bovine viral diarrhea virus infections in fetal fibroblast cells.

Authors:  M Daniel Givens; David A Stringfellow; Christine C Dykstra; Kay P Riddell; Patricia K Galik; Eddie Sullivan; James Robl; Poothapillai Kasinathan; Arvind Kumar; David W Boykin
Journal:  Antiviral Res       Date:  2004-11       Impact factor: 5.970

8.  Computational alanine scanning and free energy decomposition for E. coli type I signal peptidase with lipopeptide inhibitor complex.

Authors:  Tong Li; Matheus Froeyen; Piet Herdewijn
Journal:  J Mol Graph Model       Date:  2007-05-03       Impact factor: 2.518

9.  Identification and characterization of an RNA-dependent RNA polymerase activity within the nonstructural protein 5B region of bovine viral diarrhea virus.

Authors:  W Zhong; L L Gutshall; A M Del Vecchio
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

10.  Effects of interferon, ribavirin, and iminosugar derivatives on cells persistently infected with noncytopathic bovine viral diarrhea virus.

Authors:  David Durantel; Sandra Carrouée-Durantel; Norica Branza-Nichita; Raymond A Dwek; Nicole Zitzmann
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

View more
  6 in total

1.  Inhibition of human immunodeficiency virus type 1 replication in human cells by Debio-025, a novel cyclophilin binding agent.

Authors:  Roger G Ptak; Philippe A Gallay; Dirk Jochmans; Andrew P Halestrap; Urs T Ruegg; Luke A Pallansch; Michael D Bobardt; Marie-Pierre de Béthune; Johan Neyts; Erik De Clercq; Jean-Maurice Dumont; Pietro Scalfaro; Kamel Besseghir; Roland M Wenger; Brigitte Rosenwirth
Journal:  Antimicrob Agents Chemother       Date:  2008-01-22       Impact factor: 5.191

2.  Porcine Mx1 Protein Inhibits Classical Swine Fever Virus Replication by Targeting Nonstructural Protein NS5B.

Authors:  Jing Zhou; Jing Chen; Xiao-Min Zhang; Zhi-Can Gao; Chun-Chun Liu; Yun-Na Zhang; Jin-Xiu Hou; Zhao-Yao Li; Lin Kan; Wen-Liang Li; Bin Zhou
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

Review 3.  RNA-Dependent RNA Polymerases of Picornaviruses: From the Structure to Regulatory Mechanisms.

Authors:  Cristina Ferrer-Orta; Diego Ferrero; Núria Verdaguer
Journal:  Viruses       Date:  2015-08-06       Impact factor: 5.048

Review 4.  Molecular strategies to inhibit the replication of RNA viruses.

Authors:  Pieter Leyssen; Erik De Clercq; Johan Neyts
Journal:  Antiviral Res       Date:  2008-02-04       Impact factor: 5.970

5.  Quinolinecarboxamides Inhibit the Replication of the Bovine Viral Diarrhea Virus by Targeting a Hot Spot for the Inhibition of Pestivirus Replication in the RNA-Dependent RNA Polymerase.

Authors:  Simone Musiu; Yunierkis Perez Castillo; Alexandra Muigg; Gerhard Pürstinger; Pieter Leyssen; Mathy Froeyen; Johan Neyts; Jan Paeshuyse
Journal:  Molecules       Date:  2020-03-12       Impact factor: 4.411

Review 6.  Status presens of antiviral drugs and strategies: Part II: RNA VIRUSES (EXCEPT RETROVIRUSES).

Authors:  Erik De Clercq
Journal:  Adv Antivir Drug Des       Date:  2007-09-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.